2024å¹´

Imai T, Mitsuhashi S, Isahaya K, Shibata S, Kawai Y, OMAE Y, Yamano Y.
Wilson disease (novel ATP7B variants) with concomitant FLNC-related cardiomyopathy.
Human Genome Variation, 2024 in press. 🆕

Shoji H, Yamano Y.
The history of the Japanese Society for Neuro-infectious Diseases: Foundation, objectives, and legacy.
Intractable & Rare Diseases Research, 13(2):129-132, 2024. 🆕
doi: 10.5582/irdr.2024.01008

Mizukami H, Shiraishi M, Hino S, Kaburagi M, Matsumoto H, Hagiwara Yuta and Yamano Y.
Utility of Combining Transcranial Sonography and MIBG Myocardial Scintigraphy to Evaluate Substantia Nigra in Patients with Parkinson’s Disease.
Brain Sci, 14(6), 524, 2024. 🆕
doi.org/10.3390/brainsci14060524

Kaburagi K, Hagiwara Y, Tachikawa K, Miyake N, Akiyama H, Kawai Y, Omae Y, Tokunaga Y, Yamano Y, Shimizu T, Mitsuhashi T.
A Novel NODAL variant in a young embolic stroke patient with visceral heterotaxy.
BMC Neurology, 24(1):119, 2024.
doi.org/10.21203/rs.3.rs-2847400/v1

Imoto K, Yamamoto H, Ohkawa C, Shimada N, Ikuzawa R, Takeda H, Ohhara T, Kojima Y, Furuya N, Motoyoshi A, Migita O, Kuga A, Keira T, Wakamatsu H, Sato T, Oike N, Koike J, Yamano Y, Sunakawa Y.
An approach for improvement of the accuracy of cancer gene panel testing.
Int J Clin Oncol, 29(5):571-581, 2024. 🆕
doi: 10.1007/s10147-024-02483-6.

Yamagishi M, Kuze Y, Kobayashi S, Nakashima M, Morishima S, Kawamata T, Makiyama J, Suzuki K, Seki M, Abe K, Imamura K, Watanabe E, Tsuchiya K, Yasumatsu I, Takayama G, Hizukuri Y, Ito K, Taira Y, Nannya Y, Tojo A, Watanabe T, Tsutsumi S, Suzuki Y, Uchimaru K.
Mechanisms of action and resistance in histone methylation-targeted therapy.
Nature, 627(8002):221-228, 2024.
doi: 10.1038/s41586-024-07103-x.

Sato T, Nagai M, Watanabe O, Misu T, Takenouchi N, Ohkubo R, Ishihara S, Tsuboi Y, Katsuno M, Nakagawa M, Matsushita T, Aso Yasuhiro, Matsuura E, Tokashiki T, Mukaino A, Adachi H, Nakanishi K, Yamaguchi Y, Yamaguchi S, Yamano Y.
Multicenter, randomized, double‑blind, placebo‑controlled phase 3 study of mogamulizumab with open‑label extension study in a minimum number of patients with human T‑cell leukemia virus type‑1‑associated myelopathy.
Journal of Neurology, 271(6):3471-3485, 2024.
doi.org/10.1007/s00415-024-12239-x

Araga T, Ueda T, Yoshie T, Takao N, Ohtsubo H, Tatsuno K, Usuki N, Takaishi S, and Yamano Y.
Improvement of cerebral blood flow after balloon angioplasty and stenting for symptomatic middle cerebral artery stenosis.
Interventional Neuroradiology, 2024 Online First.
doi.org/10.1177/15910199241231148

Itabashi K, Miyazawa T, Nakashima M, Makiyama J, Uchimaru Kaoru.
Transmission of Human T-Cell Leukemia Virus Type 1 From Mother to Child and Adult T-Cell Leukemia/Lymphoma.
Comprehensive Hematology and Stem Cell Research, 2024 Online First.
doi.org/10.1016/B978-0-443-15717-2.00051-2

Takao N, Yagishita N, Araya N, Aratani S, Yamauchi J, Takahashi K, Kunitomo Y, Sato T, Nakamori M, Kawai Y, Omae Y, Tokunaga K, Matsuda Fumihiko, Mitsuhashi S and Yamano Y.
Large-Scale Whole-Genome Analysis of HTLV-1–Associated Myelopathy Identified Hereditary Spastic Paraplegias.
Neurology Genetics, 10(1):e200108, 2024.
doi/10.1212/NXG.0000000000200108